This AOP is licensed under the BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Inhibition of voltage gate sodium channels leading to impairment in learning and memory during development
Point of Contact
- Andrea Terron
- Martina Panzarea
- Nikolaos Tagaras
- Timothy Shafer
- Arthur Author
|Handbook Version||OECD status||OECD project|
This AOP was last modified on April 29, 2023 13:02
|Inhibit, voltage-gated sodium channel||March 21, 2022 08:41|
|Disruption of sodium channel gating kinetics||September 13, 2022 20:44|
|Disruption, action potential||March 31, 2022 06:46|
|Altered neurotransmission in development||May 18, 2022 11:39|
|Hippocampal anatomy, Altered||May 20, 2022 05:45|
|Altered function of the brain||July 06, 2022 10:34|
|Impairment, Learning and memory||March 22, 2023 16:30|
|Inhibit, voltage-gated sodium channel leads to Altered kinetics of sodium channel||March 31, 2022 06:51|
|Altered kinetics of sodium channel leads to Disruption in action potential generation||March 31, 2022 06:54|
|Pyrethrins and Pyrethroids||November 29, 2016 18:42|
AOP Development Strategy
Summary of the AOP
Molecular Initiating Events (MIE)
Key Events (KE)
Adverse Outcomes (AO)
|Type||Event ID||Title||Short name|
|MIE||1353||Inhibit, voltage-gated sodium channel||Inhibit, voltage-gated sodium channel|
|KE||1977||Disruption of sodium channel gating kinetics||Altered kinetics of sodium channel|
|KE||1983||Disruption, action potential||Disruption in action potential generation|
|KE||2005||Altered neurotransmission in development||neurotrasmission in development|
|KE||757||Hippocampal anatomy, Altered||Hippocampal anatomy, Altered|
|KE||2022||Altered function of the brain||brain function|
|AO||341||Impairment, Learning and memory||Impairment, Learning and memory|
Relationships Between Two Key Events (Including MIEs and AOs)
|Inhibit, voltage-gated sodium channel leads to Altered kinetics of sodium channel||adjacent|
|Altered kinetics of sodium channel leads to Disruption in action potential generation||adjacent|
Life Stage Applicability
Overall Assessment of the AOP
Domain of Applicability
Essentiality of the Key Events
Essentiality of MIE and KE1:
Evidence from mutation and knockout models demonstrates that perturbation of VGSC function during development impairs nervous system structure and function. Knockout and mutant mouse models of sodium channel α subunits demonstrate varying degrees of adverse outcomes associated with loss or alteration of specific channel subunits. When mRNA for the Nav 1.2 subunit was reduced by approximately 85%, mice exhibited reduced levels of electrical excitability, had high levels of apoptotic neurons in the brainstem and cortex, and died from severe hypoxia within 1–2 days of birth (Planells-Cases et al., 2000).
In insects, only VGSCα are codified. Pyrethroid resistant, or knockdown-resistant houseflies are well known. As this mutation does not alter expression or localisation of the VGSC, it was suspected to alter the affinity of the channel for pyrethroids. Expression of this mutant channel in Xenopus laevis oocytes resulted in VGSCs that were 10-fold less sensitive to cismethirin as assessed using voltage-clamp experiments (Wakeling et al., 2012).
In humans, some mutations have been identified in genes coding for VGSC subunits that result in neuronal hyperexcitability due to subtle changes in channel gating and inactivation (Meisler et al., 2001), these mutations have been linked to various forms of epilepsy (Shafer et al., 2005; Chahine 2018).
Pyrethroids, like these mutations, alter VGSC activation, inactivation and neuronal excitability. However, the mechanisms and magnitude of mutational versus pyrethroid effects are different as well as the duration of the effect.
Essentiality of KE1 and KE2:
The sodium channel modulator veratridine (VTD) produce the same effect as deltamethrin. In patch recording, this compound rapidly reduced the number of sEPSC without affecting the number of individual burst, but at higher concentration (1 mM) completely removed all sEPSC activity without affecting mEPSC frequency, similar to treatment to TTX (Meyer et al., 2008). Both events – sE(I)PSCs and mE(I)PSCs – are similar in the fact that they occur without any artificial stimulation. The difference between sE(I)PSCs and mE(I)PSCs is coming from the fact that for the sE(I)PSCs there is a chance of action potential-driven events due to intrinsic properties of presynaptic cell and/or network activity. All the mE(I)PSCs, in turn, are recorded in the presence of tetrodotoxin (TTX) which blocks action potential formation and its propagation, therefore mE(I)PSCs are more ‘spontaneous’ events than sE(I)PSCs and can be further used for the quantification of readily releasable pool size. So, it is useful to take both sE(I)PSCs and mE(I)PSCs from the same cell. First, one can record the sE(I)PSCs and then, by adding TTX into the bath solution the mE(I)PSCs. Having both sE(I)PSCs and mE(I)PSCs can help to understand where the changes in synaptic transmission are coming from, i.e. whether it is from the presynaptic side, or postsynaptic or both (Mayer et al., 2008). Titration with tetrodotoxin (TTX) produces a concentration-dependent reduction in the deltamethrin dependent calcium influx, indicating that the alteration in firing rate is consequent to the disruption in the VGSC (Cao et al., 2011).